Patents Represented by Attorney John J. Kolando
  • Patent number: 4954488
    Abstract: The present invention is directed to a method for the treatment of hyperaldosteronism and related disorders which comprises administering to an appropriate patient an appropriate 17.beta.-cyclopropylaminoandrostene.
    Type: Grant
    Filed: June 14, 1989
    Date of Patent: September 4, 1990
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: J. O'Neal Johnston